Until now, there has been little research on the best ways to care for geriatric patients with bipolar disorder. Now, a major National Institute of Mental Health (NIMH)- funded multi-site clinical research study—led by the Weill Cornell Institute of Geriatric Psychiatry at NewYork-Presbyterian Hospital/Westchester Division - is the first to compare the efficacy of two commonly used mood stabilizers for geriatric patients suffering from the episodes of symptoms that characterize bipolar disorder, formerly known as manic-depressive illness.

NewYork-Presbyterian/Westchester Division is the first hospital to earn green business certification through Westchester Green Business-Certified (WGB-Certified), a program launched by Westchester County and The Business Council of Westchester in 2014. The hospital accepted the award at a ceremony last month.

Your high school graduate is off to college to embark on a newly independent life. But they're not the only one making a transition: parents too face emotional and lifestyle adjustments. With advice on empty nest syndrome and the college transition, NewYork-Presbyterian Hospital physicians offer expert tips on topics including, redecorating your child's room, credit cards, keeping in touch and more.

Lymphoma is the most common blood cancer and the third most common form of childhood cancer. Two leading lymphoma oncologists at NewYork-Presbyterian Hospital—Dr. John P. Leonard and Dr. Owen A. O'Connor—are program chairs for the 2007 North American Educational Forum on Lymphoma, the largest conference in the world dedicated to offering lymphoma patients everything from information on the more than 30 subtypes of the disease to the latest in lymphoma research.

Columbia University Medical Center and NewYork-Presbyterian Hospital is one of the first medical centers in the country participating in a novel clinical trial investigating if a patient's own stem cells can treat a form of severe coronary artery disease. The Autologous Cellular Therapy CD34-Chronic Myocardial Ischemia (ACT34-CMI) trial is the first Phase II adult stem cell therapy study in the U.S. designed to investigate the efficacy, tolerability and safety of blood-derived selected CD34+ stem cells to improve symptoms and clinical outcomes in patients with chronic myocardial ischemia (CMI), a severe form of coronary artery disease.

As environmentalists have pointed out, it can be as dangerous to be outdoors behind a city bus -- walking or bicycling -- as it is to be in front of one. All the exhaust and smoke -- even when they have been reduced by clean-air technology -- can damage a person's health. The dangers of urban air pollution are of special concern to those who exercise by running, bicycling or skating. These individuals, while trying to help their bodies through exercise, should take care that they do not harm themselves through exposure to air pollution. Dr. Ronald Crystal, chief of pulmonary medicine and critical care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, says that air pollution is definitely a problem for those who work out in the city. The main culprits are ozone, fine particulate matter, and carbon monoxide, he says. These pollutants irritate the lungs and respiratory system, and can exacerbate the problems of individuals with underlying disease -- such as asthma, bronchitis, emphysema, or cardiopulmonary maladies.

In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson's disease.

A 38-year-old severely brain-injured man who has been unable to communicate or eat by mouth for 6 years now performs both tasks daily, after surgeons -- in an investigational study -- used deep brain stimulation (DBS) to try and improve function within residual brain networks that they knew were still there. The man's DBS-associated improvements in communication, complex movement and eating are unique, and the technique has never been applied to this patient population before.